SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001538210-21-000006
Filing Date
2021-11-12
Accepted
2021-11-12 07:51:14
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexi-20210930.htm   iXBRL 10-Q 1334643
2 EX-31.1 nexi-20210930xexx311.htm EX-31.1 10239
3 EX-31.2 nexi-20210930xexx312.htm EX-31.2 10432
4 EX-32.1 nexi-20210930xexx321.htm EX-32.1 4102
5 EX-32.2 nexi-20210930xexx322.htm EX-32.2 4295
  Complete submission text file 0001538210-21-000006.txt   6092726

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20210930.xsd EX-101.SCH 42840
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nexi-20210930_cal.xml EX-101.CAL 53712
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nexi-20210930_def.xml EX-101.DEF 228056
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20210930_lab.xml EX-101.LAB 586436
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20210930_pre.xml EX-101.PRE 374683
11 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20210930_htm.xml XML 928201
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 211399653
SIC: 2834 Pharmaceutical Preparations